SEC Form D · filed October 5, 2016
Promentis Pharmaceuticals, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (20)
Daniel Lawton · Milwaukee, WIExec · DirectorSteve Squinto · Milwaukee, WIDirectorTom Beck · Milwaukee, WIExec · DirectorStacey Seltzer · Milwaukee, WIDirectorPatrick Schwarz-Schuette · Milwaukee, WIDirectorChad Beyer · Milwaukee, WIExecSiew Kee Loh · Singapore, U0DirectorChris G. Bruce · Chicago, ILExecRaj L. Ganguly · Chicago, ILDirectorWilliam Montague · Denver, COExec · DirectorMerus Capital Management Iv, L.P · PALO ALTO, CADirectorZhi Yuan C. Lau · Singapore, U0Exec · DirectorKlaus Veitinger · New York, NYExec · DirectorHoward Rochestie · Santa Barbara, CAExec · DirectorChris Cooper · Cottonwood Heights, UTDirectorDavid J. Maki · Kirkland, WAExec · DirectorAdam G. Pollack · Denver, CODirectorNickolas R. Friedman · COLORADO, CODirectorNathaniel W. Gruendemann · Denver, COExecKlaus Veitinger · Newark, NJExec · Director Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗